Philadelphia-Negative ALL
Oncology·MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| 19-28z/IL-18 CAR T cells | Merus N.V. (MRUS) |
Frequently asked questions
How many drugs are in development for Philadelphia-Negative ALL?
BioSniper tracks 1 drug in development for Philadelphia-Negative ALL across 1 company.
How many clinical trials target Philadelphia-Negative ALL?
There are 1 clinical trial targeting Philadelphia-Negative ALL tracked by BioSniper.
Deep-dive into Philadelphia-Negative ALL
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis